Book a demo

Chemical intelligence powered by cypris.ai

(Z)-7-[(1S,2S,3S,5R)-3-[[(2R)-2-cyclopentyl-2-hydroxyacetyl]amino]-6,6-dimethyl-2-bicyclo[3.1.1]heptanyl]hept-5-enoic acid

(Z)-7-[(1S,2S,3S,5R)-3-[[(2R)-2-cyclopentyl-2-hydroxyacetyl]amino]-6,6-dimethyl-2-bicyclo[3.1.1]heptanyl]hept-5-enoic acid

FormulaC23H37NO4
Mol. weight391.552
PubChem CID5311334
InChIKeySXHUZJPIRVLMHY-AZPSIHDESA-N
SMILESCC1([C@@H]2C[C@H]1[C@@H]([C@H](C2)NC(=O)[C@@H](C3CCCC3)O)C/C=C\CCCC(=O)O)C
41Patents
101Research papers
3Patents - last 3 years
0Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#AssigneePatents
1Takeda GmbH10
2Vanderbilt University4
3ER Squibb and Sons LLC3
4Bristol Myers Squibb Co1
5Cumberland Pharmaceuticals Inc1
6Regeneron Pharmaceuticals Inc1

Explore the full landscape

This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.

Visit Cypris

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#CodeAreaPatents
1A61KMedicinal preparations41
2A61PTherapeutic activity (drug indications)40
3Y02AClimate change adaptation5
4C07DHeterocyclic compounds1
5C12NMicroorganisms, enzymes1
6C12QMeasuring/testing involving enzymes1
7C12YEnzyme nomenclature (EC numbers)1
8G01NInvestigating / analysing materials1

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Where research is gaining momentum

Research themes ranked by publication activity show where scientific interest is accelerating around this compound.

#Research topicPapers
1Nitric Oxide and Endothelin Effects1
2Vestibular and auditory disorders1

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#AuthorAffiliationPapers
1Hiroaki ShirahaseKyoto University8
2Noboru TodaShiga University8
3Kenji OkumuraNagoya University7
4Hachiro UsuiKyoto University6
5Hidekazu HashimotoNagoya University6
6Kazuyoshi KurahashiKyoto University6
7Motohatsu FujiwaraKyoto University5
8A. KodaGifu Pharmaceutical University4
9Alan H. StephensonSaint Louis University4
10Takayuki ItoNagoya University4

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the molecular formula and weight of this compound?

The compound has a molecular formula of C23H37NO4 and a molecular weight of 391.552 g/mol.

How many patents and papers reference this compound in the literature?

There are 41 total patents and 101 papers (by publication-graph join) covering this compound in the aggregate dataset.

Which organizations hold the most patents related to this compound?

Takeda GmbH holds the most patents with 10, followed by Vanderbilt University with 4 patents, and ER Squibb and Sons LLC with 3 patents.

What are the main CPC classifications for patents involving this compound?

The primary CPC classifications are A61K (pharmaceuticals) with 41 patents and A61P (specific therapeutic activity of chemical compounds) with 40 patents.

Which academic researchers have published the most papers on this compound?

Hiroaki Shirahase from Kyoto University and Noboru Toda from Shiga University have each published 8 papers on this compound, making them the most prolific authors in the dataset.

Turn any compound into a complete chemical intelligence landscape

Go beyond static compound data. Cypris resolves identities, patents, papers, and commercial signals into one AI-powered view - so your team can move from a single chemical question to a complete R&D, IP, and market landscape.

Schedule a free trial